Livongo Health Q3 Adj. EPS $0.16 Beats $0.05 Estimate, Sales $106.10M Beat $98.80M Estimate
Livongo Health Q3 Adj. EPS $0.16 Beats $0.05 Estimate, Sales $106.10M Beat $98.80M Estimate
Livongo Health第三季度調整後每股收益0.16美元超過預期0.05美元，銷售額1.061億美元超過預期9880萬美元
Livongo Health (NASDAQ:LVGO) reported quarterly earnings of $0.16 per share which beat the analyst consensus estimate of $0.05 by 220 percent. This is a 420 percent increase over losses of $(0.05) per share from the same period last year. The company reported quarterly sales of $106.10 million which beat the analyst consensus estimate of $98.80 million by 7.39 percent. This is a 127.40 percent increase over sales of $46.66 million the same period last year.
Livongo Health(納斯達克：LVGO)公佈的季度收益為每股0.16美元，比分析師普遍預期的0.05美元高出220%。這比去年同期每股虧損0.05美元增加了420%。該公司公佈的季度銷售額為1.061億美元，比分析師普遍預期的9880萬美元高出7.39%。這比去年同期4,666萬美元的銷售額增長了127.40%。